MATINAS BIOPHARMA HOLDINGS, INC. Diluted Shares Outstanding (Weighted Average)
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Diluted Shares Outstanding (Weighted Average) of 6.41 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 6.41M shares, a 25.93% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 6.41M shares, a 25.93% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 6.28M shares, a 23.47% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 5.44M shares, a 7.90% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 5.47M shares, a 12.50% increase from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 4.87M shares, a 11.98% increase from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 4.35M shares, a 98.00% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 216.81M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.41M shares 10-Q · filed 2026-08-13 | 6.41M shares 10-Q · filed 2026-08-13 | 6.37M shares derived: average of 3 quarters · filed 2026-08-13 | 6.13M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 6.41M shares 10-Q · filed 2026-05-08 | 6.34M shares derived: average of 2 quarters · filed 2026-05-08 | 6.04M shares derived: average of 3 quarters · filed 2026-05-08 | 5.80M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 6.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 5.86M shares derived: average of 2 quarters · filed 2026-03-31 | 5.60M shares derived: average of 3 quarters · filed 2026-08-13 | 5.47M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 5.44M shares 10-Q · filed 2025-11-10 | 5.26M shares derived: average of 2 quarters · filed 2026-08-13 | 5.20M shares 10-Q · filed 2025-11-10 | 5.17M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 5.09M shares 10-Q · filed 2026-08-13 | 5.09M shares 10-Q · filed 2026-08-13 | 5.09M shares derived: average of 3 quarters · filed 2026-08-13 | 5.08M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 5.09M shares 10-Q · filed 2026-05-08 | 5.09M shares derived: average of 2 quarters · filed 2026-05-08 | 5.07M shares derived: average of 3 quarters · filed 2026-05-08 | 5.05M shares derived: average of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | 5.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 5.06M shares derived: average of 2 quarters · filed 2026-03-31 | 5.04M shares derived: average of 3 quarters · filed 2026-03-31 | 4.87M shares 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | 5.04M shares 10-Q · filed 2025-11-10 | 5.01M shares derived: average of 2 quarters · filed 2025-11-10 | 4.79M shares 10-Q · filed 2025-11-10 | 4.68M shares derived: average of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | 4.99M shares 10-Q · filed 2025-08-14 | 249.35M shares 10-Q · filed 2024-08-14 | 4.67M shares 10-Q · filed 2025-08-14 | 233.35M shares 10-Q · filed 2024-08-14 | 4.56M shares derived: average of 3 quarters · filed 2025-08-14 | 4.51M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 4.35M shares 10-Q · filed 2025-05-15 | 217.36M shares 10-Q · filed 2024-05-09 | 4.35M shares derived: average of 2 quarters · filed 2025-05-15 | 4.35M shares derived: average of 3 quarters · filed 2025-05-15 | 57.58M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 4.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 4.35M shares derived: average of 2 quarters · filed 2025-04-15 | 75.32M shares derived: average of 3 quarters · filed 2025-04-15 | 4.35M shares 10-K · filed 2025-04-15 | 217.26M shares 10-K · filed 2024-03-27 | |||
| 2023-09-30 | 4.35M shares 10-Q · filed 2024-11-13 | 217.26M shares 10-Q · filed 2023-11-08 | 110.80M shares derived: average of 2 quarters · filed 2024-11-13 | 4.35M shares 10-Q · filed 2024-11-13 | 217.26M shares 10-Q · filed 2023-11-08 | 163.94M shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 217.26M shares 10-Q · filed 2024-08-14 | 217.26M shares 10-Q · filed 2024-08-14 | 217.13M shares derived: average of 3 quarters · filed 2024-08-14 | 217.07M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 217.26M shares 10-Q · filed 2024-05-09 | 217.07M shares derived: average of 2 quarters · filed 2024-05-09 | 217.00M shares derived: average of 3 quarters · filed 2024-05-09 | 216.97M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 216.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 216.87M shares derived: average of 2 quarters · filed 2024-03-27 | 216.87M shares derived: average of 3 quarters · filed 2024-03-27 | 216.81M shares 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | 216.86M shares 10-Q · filed 2023-11-08 | 216.86M shares derived: average of 2 quarters · filed 2023-11-08 | 216.79M shares 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | 216.86M shares 10-Q · filed 2023-08-09 | 216.76M shares 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |